vs

Side-by-side financial comparison of CHOICEONE FINANCIAL SERVICES INC (COFS) and NEKTAR THERAPEUTICS (NKTR). Click either name above to swap in a different company.

CHOICEONE FINANCIAL SERVICES INC is the larger business by last-quarter revenue ($42.9M vs $21.8M, roughly 2.0× NEKTAR THERAPEUTICS). On growth, CHOICEONE FINANCIAL SERVICES INC posted the faster year-over-year revenue change (76.4% vs -25.3%). CHOICEONE FINANCIAL SERVICES INC produced more free cash flow last quarter ($25.2M vs $-65.0M). Over the past eight quarters, CHOICEONE FINANCIAL SERVICES INC's revenue compounded faster (15.0% CAGR vs 0.4%).

ChoiceOne Financial Services Inc is a US regional financial holding company that operates through its banking subsidiary, offering personal and commercial banking products including savings accounts, loans, wealth management, and insurance services primarily to consumers, small businesses, and corporate clients across Michigan.

Nektar Therapeutics is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances, which improves drug characteristics like retention and solubility. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, e...

COFS vs NKTR — Head-to-Head

Bigger by revenue
COFS
COFS
2.0× larger
COFS
$42.9M
$21.8M
NKTR
Growing faster (revenue YoY)
COFS
COFS
+101.6% gap
COFS
76.4%
-25.3%
NKTR
More free cash flow
COFS
COFS
$90.2M more FCF
COFS
$25.2M
$-65.0M
NKTR
Faster 2-yr revenue CAGR
COFS
COFS
Annualised
COFS
15.0%
0.4%
NKTR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
COFS
COFS
NKTR
NKTR
Revenue
$42.9M
$21.8M
Net Profit
$-36.1M
Gross Margin
Operating Margin
39.1%
-126.9%
Net Margin
-165.4%
Revenue YoY
76.4%
-25.3%
Net Profit YoY
-596.9%
EPS (diluted)
$1.43
$-4.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COFS
COFS
NKTR
NKTR
Q4 25
$42.9M
$21.8M
Q3 25
$61.8M
$11.8M
Q2 25
$60.4M
$11.2M
Q1 25
$44.9M
$10.5M
Q4 24
$24.3M
$29.2M
Q3 24
$36.6M
$24.1M
Q2 24
$34.0M
$23.5M
Q1 24
$32.5M
$21.6M
Net Profit
COFS
COFS
NKTR
NKTR
Q4 25
$-36.1M
Q3 25
$14.7M
$-35.5M
Q2 25
$13.5M
$-41.6M
Q1 25
$-13.9M
$-50.9M
Q4 24
$7.3M
Q3 24
$7.3M
$-37.1M
Q2 24
$6.6M
$-52.4M
Q1 24
$5.6M
$-36.8M
Gross Margin
COFS
COFS
NKTR
NKTR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
72.7%
Q3 24
81.6%
Q2 24
58.5%
Q1 24
60.6%
Operating Margin
COFS
COFS
NKTR
NKTR
Q4 25
39.1%
-126.9%
Q3 25
29.6%
-268.6%
Q2 25
27.6%
-324.2%
Q1 25
-39.2%
-425.8%
Q4 24
36.1%
49.2%
Q3 24
25.4%
-142.4%
Q2 24
24.0%
-211.9%
Q1 24
21.1%
-163.7%
Net Margin
COFS
COFS
NKTR
NKTR
Q4 25
-165.4%
Q3 25
23.7%
-301.3%
Q2 25
22.4%
-372.2%
Q1 25
-31.0%
-486.4%
Q4 24
24.9%
Q3 24
20.1%
-153.6%
Q2 24
19.4%
-222.9%
Q1 24
17.3%
-170.1%
EPS (diluted)
COFS
COFS
NKTR
NKTR
Q4 25
$1.43
$-4.67
Q3 25
$0.97
$-1.87
Q2 25
$0.90
$-2.95
Q1 25
$-1.29
$-0.24
Q4 24
$0.79
$-2.07
Q3 24
$0.85
$-2.66
Q2 24
$0.87
$-3.76
Q1 24
$0.74
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COFS
COFS
NKTR
NKTR
Cash + ST InvestmentsLiquidity on hand
$88.0M
$15.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$465.4M
$89.8M
Total Assets
$4.4B
$280.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COFS
COFS
NKTR
NKTR
Q4 25
$88.0M
$15.1M
Q3 25
$99.0M
$41.0M
Q2 25
$156.3M
$43.0M
Q1 25
$139.4M
$38.9M
Q4 24
$96.8M
$44.3M
Q3 24
$145.9M
$30.1M
Q2 24
$101.0M
$27.9M
Q1 24
$150.1M
$48.6M
Stockholders' Equity
COFS
COFS
NKTR
NKTR
Q4 25
$465.4M
$89.8M
Q3 25
$449.6M
$85.1M
Q2 25
$431.8M
$-24.2M
Q1 25
$427.1M
$13.7M
Q4 24
$260.4M
$60.7M
Q3 24
$247.7M
$48.9M
Q2 24
$214.5M
$79.7M
Q1 24
$206.8M
$126.7M
Total Assets
COFS
COFS
NKTR
NKTR
Q4 25
$4.4B
$280.4M
Q3 25
$4.3B
$301.3M
Q2 25
$4.3B
$207.5M
Q1 25
$4.3B
$256.2M
Q4 24
$2.7B
$303.9M
Q3 24
$2.7B
$308.0M
Q2 24
$2.7B
$343.3M
Q1 24
$2.7B
$396.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COFS
COFS
NKTR
NKTR
Operating Cash FlowLast quarter
$31.8M
$-65.0M
Free Cash FlowOCF − Capex
$25.2M
$-65.0M
FCF MarginFCF / Revenue
58.7%
-298.0%
Capex IntensityCapex / Revenue
15.4%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$38.5M
$-208.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COFS
COFS
NKTR
NKTR
Q4 25
$31.8M
$-65.0M
Q3 25
$15.3M
$-48.8M
Q2 25
$9.0M
$-45.7M
Q1 25
$-6.5M
$-49.1M
Q4 24
$47.1M
$-46.2M
Q3 24
$-7.4M
$-43.9M
Q2 24
$15.7M
$-37.7M
Q1 24
$15.3M
$-47.9M
Free Cash Flow
COFS
COFS
NKTR
NKTR
Q4 25
$25.2M
$-65.0M
Q3 25
$13.7M
$-48.9M
Q2 25
$6.9M
$-45.8M
Q1 25
$-7.3M
$-49.1M
Q4 24
$45.4M
$-46.6M
Q3 24
$-7.6M
$-44.6M
Q2 24
$15.3M
$-37.9M
Q1 24
$15.0M
$-48.0M
FCF Margin
COFS
COFS
NKTR
NKTR
Q4 25
58.7%
-298.0%
Q3 25
22.1%
-414.5%
Q2 25
11.4%
-409.6%
Q1 25
-16.3%
-469.0%
Q4 24
186.4%
-159.9%
Q3 24
-20.8%
-184.9%
Q2 24
44.8%
-161.3%
Q1 24
46.2%
-222.0%
Capex Intensity
COFS
COFS
NKTR
NKTR
Q4 25
15.4%
0.1%
Q3 25
2.6%
1.0%
Q2 25
3.4%
0.3%
Q1 25
1.9%
0.0%
Q4 24
7.0%
1.6%
Q3 24
0.7%
2.8%
Q2 24
1.4%
0.8%
Q1 24
1.0%
0.7%
Cash Conversion
COFS
COFS
NKTR
NKTR
Q4 25
Q3 25
1.04×
Q2 25
0.66×
Q1 25
Q4 24
-6.36×
Q3 24
-1.00×
Q2 24
2.39×
Q1 24
2.72×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons